Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionShuai Xia, Lu Lu, Wei Xu et al.|Cell Research|2020Cited by 1.4k
Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionShuai Xia, Lu Lu, Chao Wang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 14